10 likes | 75 Views
Supplementary Figure 1 displays the enhanced cleaved PARP expression with co-treatment of Gemcitabine at 10-7M and CHIR-124 at 2x10-8M in contrast to control groups. This synergistic effect highlights a potential therapeutic strategy in cancer treatment.
E N D
Gemcitabine 10-7M CHIR-124 2x10-8M Control Gemcitabine 10-7M CHIR-124 2x10-8M Cleaved PARP Supplementary figure 1